BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 30004130)

  • 1. The Microbiota-Inflammasome Hypothesis of Major Depression.
    Inserra A; Rogers GB; Licinio J; Wong ML
    Bioessays; 2018 Sep; 40(9):e1800027. PubMed ID: 30004130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition.
    Wong ML; Inserra A; Lewis MD; Mastronardi CA; Leong L; Choo J; Kentish S; Xie P; Morrison M; Wesselingh SL; Rogers GB; Licinio J
    Mol Psychiatry; 2016 Jun; 21(6):797-805. PubMed ID: 27090302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications?
    Pellegrini C; Antonioli L; Calderone V; Colucci R; Fornai M; Blandizzi C
    Prog Neurobiol; 2020 Aug; 191():101806. PubMed ID: 32473843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLRP3 inflammasome-driven pathways in depression: Clinical and preclinical findings.
    Kaufmann FN; Costa AP; Ghisleni G; Diaz AP; Rodrigues ALS; Peluffo H; Kaster MP
    Brain Behav Immun; 2017 Aug; 64():367-383. PubMed ID: 28263786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota decreased inflammation induced by chronic unpredictable mild stress through affecting NLRP3 inflammasome.
    Huang L; Ma Z; Ze X; Zhao X; Zhang M; Lv X; Zheng Y; Liu H
    Front Cell Infect Microbiol; 2023; 13():1189008. PubMed ID: 37293210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota dysbiosis contributes to depression-like behaviors via hippocampal NLRP3-mediated neuroinflammation in a postpartum depression mouse model.
    Xu Q; Sun L; Chen Q; Jiao C; Wang Y; Li H; Xie J; Zhu F; Wang J; Zhang W; Xie L; Wu H; Zuo Z; Chen X
    Brain Behav Immun; 2024 Jul; 119():220-235. PubMed ID: 38599497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome.
    Zhang Y; Zhang S; Li B; Luo Y; Gong Y; Jin X; Zhang J; Zhou Y; Zhuo X; Wang Z; Zhao X; Han X; Gao Y; Yu H; Liang D; Zhao S; Sun D; Wang D; Xu W; Qu G; Bo W; Li D; Wu Y; Li Y
    Cardiovasc Res; 2022 Feb; 118(3):785-797. PubMed ID: 33757127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism.
    Zheng P; Zeng B; Zhou C; Liu M; Fang Z; Xu X; Zeng L; Chen J; Fan S; Du X; Zhang X; Yang D; Yang Y; Meng H; Li W; Melgiri ND; Licinio J; Wei H; Xie P
    Mol Psychiatry; 2016 Jun; 21(6):786-96. PubMed ID: 27067014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between Gut Microbiota and NLRP3 Inflammasome in Intracerebral Hemorrhage.
    Zhang Y; Yu W; Flynn C; Chang W; Zhang L; Wang M; Zheng W; Li P
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota dysbiosis in hyperuricaemia promotes renal injury through the activation of NLRP3 inflammasome.
    Zhou X; Ji S; Chen L; Liu X; Deng Y; You Y; Wang M; He Q; Peng B; Yang Y; Chen X; Kwan HY; Zhou L; Chen J; Zhao X
    Microbiome; 2024 Jun; 12(1):109. PubMed ID: 38907332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The crosstalk between NLRP3 inflammasome and gut microbiome in atherosclerosis.
    Zhang XN; Yu ZL; Chen JY; Li XY; Wang ZP; Wu M; Liu LT
    Pharmacol Res; 2022 Jul; 181():106289. PubMed ID: 35671922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between atrial fibrillation and NLRP3 inflammasome: a gut microbiota perspective.
    Xing Y; Yan L; Li X; Xu Z; Wu X; Gao H; Chen Y; Ma X; Liu J; Zhang J
    Front Immunol; 2023; 14():1273524. PubMed ID: 38077349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major Depressive Disorder and gut microbiota - Association not causation. A scoping review.
    Łoniewski I; Misera A; Skonieczna-Żydecka K; Kaczmarczyk M; Kaźmierczak-Siedlecka K; Misiak B; Marlicz W; Samochowiec J
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110111. PubMed ID: 32976952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota regulates chronic ethanol exposure-induced depressive-like behavior through hippocampal NLRP3-mediated neuroinflammation.
    Yao H; Zhang D; Yu H; Yuan H; Shen H; Lan X; Liu H; Chen X; Meng F; Wu X; Zhang G; Wang X
    Mol Psychiatry; 2023 Feb; 28(2):919-930. PubMed ID: 36280756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Potential Role of Gut Microbiota in the Pathogenesis of Type 2 Diabetes Mellitus
    Sharma B; Kumar A; Sharma U; Pal D; Prashar S
    Endocr Metab Immune Disord Drug Targets; 2022; 22(14):1331-1343. PubMed ID: 35362379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammasomes on the Crossroads of Innate Immune Recognition and Metabolic Control.
    Próchnicki T; Latz E
    Cell Metab; 2017 Jul; 26(1):71-93. PubMed ID: 28683296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal microbiota transplantation ameliorates stress-induced depression-like behaviors associated with the inhibition of glial and NLRP3 inflammasome in rat brain.
    Rao J; Qiao Y; Xie R; Lin L; Jiang J; Wang C; Li G
    J Psychiatr Res; 2021 May; 137():147-157. PubMed ID: 33677218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology.
    Rutsch A; Kantsjö JB; Ronchi F
    Front Immunol; 2020; 11():604179. PubMed ID: 33362788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gutted! Unraveling the Role of the Microbiome in Major Depressive Disorder.
    Bastiaanssen TFS; Cussotto S; Claesson MJ; Clarke G; Dinan TG; Cryan JF
    Harv Rev Psychiatry; 2020; 28(1):26-39. PubMed ID: 31913980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressants induce autophagy dependent-NLRP3-inflammasome inhibition in Major depressive disorder.
    Alcocer-Gómez E; Casas-Barquero N; Williams MR; Romero-Guillena SL; Cañadas-Lozano D; Bullón P; Sánchez-Alcazar JA; Navarro-Pando JM; Cordero MD
    Pharmacol Res; 2017 Jul; 121():114-121. PubMed ID: 28465217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.